AptarGroup, Inc.

ATR Healthcare Medical Instruments & Supplies

AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024.

Revenue
+6.03%
EPS
−73.9%
Free cash flow
−16.9%
Total debt
+14.6%

Quarter to September 2026, against a year earlier

143.84 3.02 −2.06%
Market cap
$9.1B
P/E
34.6×
Fwd P/E
25.9×
Dividend yield
1.00%
F-score
5/9
Altman Z
3.78
Beneish M
−2.48
Dividend safety
92/100
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
29.13 22.36 21.32 20.43

+8 more quarters

P/S ratio
1.93 2.03 2.08 2.12
P/FCF ratio
26.09 25.33 24.56 26.90
P/Operating CF
45.92 76.99 68.00 43.65
P/B ratio
2.92 3.01 3.05 2.99
EV/Sales
2.22 2.32 2.38 2.41
EV/EBITDA
11.32 11.65 11.62 11.53
EV/FCF
30.03 29.05 28.02 30.50
Current Ratio
1.50 1.61 1.66 1.62
Net Debt/EBITDA
5.52 5.67 6.20 5.87
Debt/Equity
0.52 0.52 0.52 0.55
Earnings Yield
3.43% 4.47% 4.69% 4.90%
Free Cash Flow Yield
3.83% 3.95% 4.07% 3.72%
Free Cash Flow per Share
1.52 0.74 0.84 1.48
Book value per Share
41.45 41.59 41.34 40.86
Free Cash Flow
96.46 46.93 54.03 97.60
EV/EBIT
18.63 19.14 18.60 18.14
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026